News Articles Tagged: Cancer Models

The Role of MNNG in Inducing Gastric Carcinoma Models

Discover how 1-Methyl-3-nitro-1-nitrosoguanidine (MNNG) is utilized by manufacturers and researchers to create vital gastric carcinoma models for disease study.

Exploring the Efficacy of GSK2636771 in Preclinical Cancer Models

Investigate the preclinical efficacy of GSK2636771, a selective PI3K beta inhibitor, in various cancer models and its potential in advancing targeted cancer therapies.

CB-839: A Versatile GLS1 Inhibitor for Preclinical Oncology Studies

Discover the preclinical applications of CB-839, a potent glutaminase GLS1 inhibitor, in various cancer models and combination therapies.

Ipatasertib in Vivo: Demonstrating Antitumor Activity in Preclinical Models

Examine the in vivo efficacy of Ipatasertib in preclinical cancer models, highlighting its antitumor effects and the critical role of PUMA.

VAL-201: A Promising Peptide in Cancer Models and Pharmaceutical Research

This article examines VAL-201, a peptide with demonstrated promise in cancer models and significant utility in pharmaceutical research as a chemical reagent and intermediate.